Please use this identifier to cite or link to this item: http://cmuir.cmu.ac.th/jspui/handle/6653943832/57772
Full metadata record
DC FieldValueLanguage
dc.contributor.authorColin F. Royseen_US
dc.contributor.authorLeif Saageren_US
dc.contributor.authorRichard Whitlocken_US
dc.contributor.authorJared Ou-Youngen_US
dc.contributor.authorAlistair Royseen_US
dc.contributor.authorJessica Vincenten_US
dc.contributor.authorP. J. Devereauxen_US
dc.contributor.authorAndrea Kurzen_US
dc.contributor.authorAhmed Awaisen_US
dc.contributor.authorKrit Panjasawatwongen_US
dc.contributor.authorDaniel I. Sessleren_US
dc.date.accessioned2018-09-05T03:49:33Z-
dc.date.available2018-09-05T03:49:33Z-
dc.date.issued2017-02-01en_US
dc.identifier.issn15281175en_US
dc.identifier.issn00033022en_US
dc.identifier.other2-s2.0-84992348995en_US
dc.identifier.other10.1097/ALN.0000000000001433en_US
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84992348995&origin=inwarden_US
dc.identifier.urihttp://cmuir.cmu.ac.th/jspui/handle/6653943832/57772-
dc.description.abstractBackground: Inflammation after cardiopulmonary bypass may contribute to postoperative delirium and cognitive dysfunction. The authors evaluated the effect of high-dose methylprednisolone to suppress inflammation on the incidence of delirium and postoperative quality of recovery after cardiac surgery. Methods: Five hundred fifty-five adults from three hospitals enrolled in the randomized, double-blind Steroids in Cardiac Surgery trial were randomly allocated to placebo or 250 mg methylprednisolone at induction and 250 mg methylprednisolone before cardiopulmonary bypass. Each completed the Postoperative Quality of Recovery Scale before surgery and on days 1, 2, and 3 and 1 and 6 months after surgery and the Confusion Assessment Method scale for delirium on days 1, 2, and 3. Recovery was defined as returning to preoperative values or improvement at each time point. Results: Four hundred eighty-two participants for recovery and 498 participants for delirium were available for analysis. The quality of recovery improved over time but without differences between groups in the primary endpoint of overall recovery (odds ratio range over individual time points for methylprednisolone, 0.39 to 1.45; 95% CI, 0.08-2.04 to 0.40-5.27; P = 0.943) or individual recovery domains (all P > 0.05). The incidence of delirium was 10% (control) versus 8% (methylprednisolone; P = 0.357), with no differences in delirium subdomains (all P > 0.05). In participants with normal (51%) and low baseline cognition (49%), there were no significant differences favoring methylprednisolone in any domain (all P > 0.05). Recovery was worse in patients with postoperative delirium in the cognitive (P = 0.004) and physiologic (P < 0.001) domains. Conclusions: High-dose intraoperative methylprednisolone neither reduces delirium nor improves the quality of recovery in high-risk cardiac surgical patients.en_US
dc.subjectMedicineen_US
dc.titleImpact of Methylprednisolone on Postoperative Quality of Recovery and Delirium in the Steroids in Cardiac Surgery Trial: A Randomized, Double-blind, Placebo-controlled Substudyen_US
dc.typeJournalen_US
article.title.sourcetitleAnesthesiologyen_US
article.volume126en_US
article.stream.affiliationsUniversity of Melbourneen_US
article.stream.affiliationsDepartment of Anaesthesia and Pain Managementen_US
article.stream.affiliationsRoyal Melbourne Hospitalen_US
article.stream.affiliationsCleveland Clinic Foundationen_US
article.stream.affiliationsHamilton Health Sciencesen_US
article.stream.affiliationsChiang Mai Universityen_US
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.


Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.